These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 15515654

  • 21. Neurophysiologic and intellectual evaluation of beta-thalassemia patients.
    Economou M, Zafeiriou DI, Kontopoulos E, Gompakis N, Koussi A, Perifanis V, Athanassiou-Metaxa M.
    Brain Dev; 2006 Jan; 28(1):14-8. PubMed ID: 15925466
    [Abstract] [Full Text] [Related]

  • 22. Comparison of auditory steady-state responses and auditory brainstem responses in audiometric assessment of adults with sensorineural hearing loss.
    Lin YH, Ho HC, Wu HP.
    Auris Nasus Larynx; 2009 Apr; 36(2):140-5. PubMed ID: 18620826
    [Abstract] [Full Text] [Related]

  • 23. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR, De Sanctis V, Gilli G.
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
    [Abstract] [Full Text] [Related]

  • 24. Audiologic and vestibular assessment in children and adolescents with transfusion dependent beta thalassemia major: The era of deferasirox film coated tablet.
    Galhom DH, Talaat RM, Hanna D, Gad NH.
    Int J Pediatr Otorhinolaryngol; 2024 Feb; 177():111868. PubMed ID: 38252990
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of the incidence of sensorineural hearing loss in beta-thalassemia major patients under regular chelation therapy with desferrioxamine.
    Karimi M, Asadi-Pooya AA, Khademi B, Asadi-Pooya K, Yarmohammadi H.
    Acta Haematol; 2002 Feb; 108(2):79-83. PubMed ID: 12187025
    [Abstract] [Full Text] [Related]

  • 26. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF.
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [Abstract] [Full Text] [Related]

  • 27. High-dose intravenous desferrioxamine (DFO) delivery in four thalassemic patients allergic to subcutaneous DFO administration.
    Lombardo T, Ferro G, Frontini V, Percolla S.
    Am J Hematol; 1996 Jan; 51(1):90-2. PubMed ID: 8571945
    [Abstract] [Full Text] [Related]

  • 28. Can deferoxamine be considered an ototoxic drug?
    Masala W, Meloni F, Gallisai D, Careddu M, Secchi G, Cuccuru GB, Loriga V, Salvo G.
    Scand Audiol Suppl; 1988 Jan; 30():237-8. PubMed ID: 3227279
    [Abstract] [Full Text] [Related]

  • 29. Auditory and visual toxicity during deferoxamine therapy in transfusion-dependent patients.
    Chen SH, Liang DC, Lin HC, Cheng SY, Chen LJ, Liu HC.
    J Pediatr Hematol Oncol; 2005 Dec; 27(12):651-3. PubMed ID: 16344669
    [Abstract] [Full Text] [Related]

  • 30. Prevalence of auditory neuropathy/synaptopathy in a population of children with profound hearing loss.
    Foerst A, Beutner D, Lang-Roth R, Huttenbrink KB, von Wedel H, Walger M.
    Int J Pediatr Otorhinolaryngol; 2006 Aug; 70(8):1415-22. PubMed ID: 16574250
    [Abstract] [Full Text] [Related]

  • 31. Neurophysiological and neuro-otological study of homozygous beta-thalassemia under long-term desferrioxamine (DFO) treatment.
    Triantafyllou N, Fisfis M, Sideris G, Triantafyllou D, Rombos A, Vrettou H, Mantouvalos V, Politi C, Malliara S, Papageorgiou C.
    Acta Neurol Scand; 1991 May; 83(5):306-8. PubMed ID: 1648295
    [Abstract] [Full Text] [Related]

  • 32. [Therapeuetic management of patients with thalassemia major].
    Thuret I.
    Bull Soc Pathol Exot; 2001 May; 94(2):95-7. PubMed ID: 11475036
    [Abstract] [Full Text] [Related]

  • 33. Factors associated with sensorineural hearing loss among survivors of extracorporeal membrane oxygenation therapy.
    Fligor BJ, Neault MW, Mullen CH, Feldman HA, Jones DT.
    Pediatrics; 2005 Jun; 115(6):1519-28. PubMed ID: 15930212
    [Abstract] [Full Text] [Related]

  • 34. Hearing assessment in pre-school children with speech delay.
    Psillas G, Psifidis A, Antoniadou-Hitoglou M, Kouloulas A.
    Auris Nasus Larynx; 2006 Sep; 33(3):259-63. PubMed ID: 16420975
    [Abstract] [Full Text] [Related]

  • 35. Hearing loss in children with sickle cell disease.
    Koussi A, Zafeiriou DI, Kontzoglou G, Tsatra I, Noussios G, Athanassiou M.
    Acta Otorhinolaryngol Belg; 2001 Sep; 55(3):235-9. PubMed ID: 11685961
    [Abstract] [Full Text] [Related]

  • 36. Otological findings among Nigerian children with sickle cell anaemia.
    Alabi S, Ernest K, Eletta P, Owolabi A, Afolabi A, Suleiman O.
    Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):659-63. PubMed ID: 18336922
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Surgical findings and long-term hearing results in 3,050 stapedotomies for primary otosclerosis: a prospective study with the otology-neurotology database.
    Vincent R, Sperling NM, Oates J, Jindal M.
    Otol Neurotol; 2006 Dec; 27(8 Suppl 2):S25-47. PubMed ID: 16985478
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.